← FDA DRUG APPROVALS

FDA ANDA · ANDA071639

IBUPROFEN

Sponsor: PH HEALTH

APPLICATION
ANDA071639
TYPE
ANDA
ORIGINAL APPROVAL
1988-02-02
LATEST ACTION
1991-07-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFENDiscontinued
IBUPROFEN 200MG · TABLET · ORAL

Approval history

1991-07-25Manufacturing (CMC) · Supplement 7AP
1991-05-03Manufacturing (CMC) · Supplement 4AP
1988-06-09Manufacturing (CMC) · Supplement 1AP
1988-06-09Manufacturing (CMC) · Supplement 2AP
1988-02-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →